4/A: NeoGenomics General Counsel Amends Stock Transaction Filing After Reporting Error

NeoGenomics' General Counsel, Alicia C. Olivo, amended a previous Form 4 filing to correct an error in reporting the number of shares owned after a restricted stock unit vesting.

Summary

• Alicia C. Olivo, General Counsel at NeoGenomics, filed an amended Form 4 to correct a previous error.
• The original filing on May 14, 2024, incorrectly reported the number of shares received upon the vesting of restricted stock units (RSUs).
• The corrected filing shows that Ms. Olivo directly owns 39,414 shares of common stock after the vesting of 6,502 RSUs and a related tax withholding.
• The error in the original filing also affected the number of shares reported in subsequent Form 4 filings by Ms. Olivo.
• The vesting of 6,502 RSUs occurred on May 11, 2024, and resulted in the acquisition of 6,502 shares of common stock.
• A portion of the shares (1,584) were disposed of to cover tax obligations at a price of $14.86 per share.

Sentiment

Score: 6

Explanation: The document is neutral, it is a correction of a previous error. While the error is a negative, the correction is a positive. Overall, it is a standard regulatory filing.

Negatives

• The need for an amended filing indicates an initial error in reporting stock transactions.
• The error in the original filing affected subsequent filings, requiring further corrections.

Risks

• Errors in reporting stock transactions can lead to regulatory scrutiny and potential penalties.
• Inaccurate filings can erode investor confidence in the company's internal controls.

Management Comments

• Ms. Olivo signed the amended filing, acknowledging the correction.

Industry Context

This type of filing is standard for company insiders who have transactions in their company's stock. The amendment highlights the importance of accurate reporting in compliance with SEC regulations.

Comparison to Industry Standards

• Form 4 filings are a standard requirement for corporate insiders across all publicly traded companies in the US.
• The need for an amendment is not uncommon, but it does highlight the importance of internal controls and accurate reporting.
• Companies like Exact Sciences (EXAS) and Guardant Health (GH) also have similar insider transaction filings, and any errors would require similar amendments.

Stakeholder Impact

• The correction of the filing ensures accurate information for shareholders and the public.
• The error and subsequent correction may cause some minor concern among investors regarding internal controls.

Key Dates

Keywords

Form 4, amendment, stock ownership, restricted stock units, RSU, NeoGenomics, insider trading, SEC filing, vesting, tax withholding